Drug application
PROMETH W/ DEXTROMETHORPHAN (DEXTROMETHORPHAN HYDROBROMIDE, PROMETHAZINE HYDROCHLORIDE)
Drugs@FDA ANDA 088762 · G AND W LABS INC
Key facts
| Drug name | PROMETH W/ DEXTROMETHORPHAN |
|---|---|
| Active ingredients | DEXTROMETHORPHAN HYDROBROMIDE, PROMETHAZINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 088762 |
| Company | G AND W LABS INC |
| Dosage forms | SYRUP, ORAL |
| Strength | 15MG/5ML;6.25MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Oct 31, 1984 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.